News & Events

Keep up to date on AgNovos events and related news

Featured posts

News

AgNovos Bioscience Announces 150th Patient Enrolled in RESTORE

8/8/2023

AgNovos Bioscience announces that more than 150 patients have been enrolled in the RESTORE randomized, controlled trial of AGN1 LOEP.

News

Corporate Rebranding Announcement

2/9/2023

AgNovos Healthcare Announces Corporate Renaming as AgNovos Bioscience

News

AgNovos Healthcare Completes Enrollment for CONFIRM Clinical Study

1/11/2022

AgNovos Healthcare is pleased to announce the completion of enrollment for its CONFIRM clinical study.

News

New Manuscript on Using AGN1 Implant Material to Treat Bone Loss Published in Peer-Reviewed Journal

11/4/2021

AgNovos Healthcare is pleased to announce the publication of a manuscript titled “AGN1 implant material to treat bone loss: Resorbable implant forms normal bone with and without alendronate in a canine critical size humeral defect model” in the peer-reviewed journal Bone.

All Articles

AgNovos Healthcare Hires Adam Lowe as Vice President of Operations and Quality

3/30/2015 | News

AgNovos is pleased to announce that Mr. Adam Lowe has joined the Company as Vice President of Operations and Quality.

Find out more

AgNovos Healthcare Hires Paul Higham, PhD as Chief Scientific Officer

2/2/2015 | News

AgNovos is pleased to announce that Paul Higham, PhD has joined the Company as Chief Scientific Officer.

Find out more

1
2
3
4
5
6
7
8
9
10
11
12